Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Goodbody Health Limited GDBYF OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • CA • USD

SharesGrow Score
44/100
1/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Goodbody Health Limited (GDBYF) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector, currently trading at $0.00. It has a SharesGrow Score of 41/100, indicating a mixed investment profile with 1 out of 7 criteria passed.

Financials: revenue is $17M, +337.8%/yr average growth. Net income is $2M (loss), growing at -320.2%/yr. Net profit margin is -13.6% (negative). Gross margin is 52.4% (+52.4 pp trend).

Balance sheet: total debt is $336,953 against $7M equity (Debt-to-Equity (D/E) ratio 0.05, conservative). Current ratio is 2.03 (strong liquidity). Debt-to-assets is 3.1%. Total assets: $11M.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 58/100 (Partial), Past 0/100 (Fail), Health 100/100 (Pass), Moat 50/100 (Partial), Future ?/100 (Fail), Income 10/100 (Fail).

GDBYF SharesGrow Score Overview

55/100
SharesGrow Score
Above average fundamentals
View full scorecard →
VALUE 0/100
Valuation — P/E, PEG, Forward PEG
GROWTH 58/100
Financials — average growth
PAST 0/100
strong — trend
HEALTH 100/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 50/100
Gross margin is + market cap
FUTURE 0/100
Analyst outlook — as buy
INCOME 10/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — GDBYF

—
VALUE N/A
N/A
No analyst coverage available for this stock.
~
GROWTH Partial
58/100
GDBYF: +337.8%/yr revenue is, -320.2%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
—
PAST N/A
N/A
No analyst coverage available for this stock.
✓
HEALTH Pass
100/100
Balance sheet GDBYF: Debt-to-Equity (D/E) ratio 0.05 (conservative), Current ratio is 2.03 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
~
MOAT Partial
50/100
GDBYF: Gross margin is 52.4% (+52.4 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 50/100. ≥ 70 = Pass.
View details →
—
FUTURE N/A
N/A
No analyst coverage available for this stock.
✗
INCOME Fail
10/100
GDBYF: Net profit margin is -13.6%. negative. Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range0.00001-0.0001
Volume20
Avg Volume (30D)10
Market Cap$365.00
Beta (1Y)9.86
Share Statistics
EPS (TTM)-0.07
Shares Outstanding$34.62M
IPO Date2019-05-07
CEOGeremy Howard Prance Thomas
Financial Highlights & Ratios
Revenue (TTM)$17.06M
Gross Profit$8.93M
EBITDA$-13.74K
Net Income$-2.31M
Operating Income$-1.06M
Total Cash$6.07M
Total Debt$336.95K
Net Debt$-5.73M
Total Assets$10.84M
Price / Earnings (P/E)-0
Price / Sales (P/S)0
Analyst Forecast
Company Info
CountryCA
ExchangeOther OTC
CurrencyUSD
ISINGG00BP6KMG85

Price Chart

Track all markets on TradingView
GDBYF
Goodbody Health Limited ↗  ·  Other OTC
Healthcare • Drug Manufacturers - Specialty & Generic
0.00 52WK RANGE 0.00

People Also View

MKKGY
MKKGY
MERCK Kommanditgesellschaft auf Aktien
$27.41
+2.47%
 MKGAF
MKGAF
MERCK Kommanditgesellschaft auf Aktien
$133.78
+3.43%
 LOVFF
LOVFF
Cannara Biotech Inc.
$1.39
-3.46%
 AVCNF
AVCNF
Avicanna Inc.
$0.11
-2.06%
 BBRRF
BBRRF
Blueberries Medical Corp.
$0.01
-24.00%
 SHMN
SHMN
SOHM, Inc.
$0.00
+0.00%
 EXMT
EXMT
Anything Technologies Media, Inc.
$0.00
-5.71%
 MSMY
MSMY
MC Endeavors, Inc.
$0.00
-44.44%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message